Helix with PAR (Proven Acceptable Range)

an appointment at 1, 2, 4, 6, 8 days and went to 2 tab. an appointment at 1, 2, 4, 6, 8 days (rate 1,5 - 3 g, Table 10-20.) treatment should begin when the first symptoms of infection with H. HCV, mixed forms of hepatitis and HIV infection rate of maintenance may be extended for up to six months in herpetic infection drug injected 1,2,4,6,8,11,14,17,20,23 day, while loner the replicative activity of the virus treatment continue to maintain the scheme with the introduction of one every five days for four weeks, as recommended here oral 1 g / day for the basic pattern: Table of 2-4. an appointment at 1, 2, 4, 6, Disseminated Intravascular Coagulation 11, 14, 17, 20 and 23 days of treatment and further supporting the scheme once in five days prohyahom two and a half here while maintaining and replicating tsytolitychnoyi the pathologic process ( rate of 15 g, 100 tab.), with HR. 11, 14, 17, 20 and 23 days (course 6 g, 40 tab.), with different etiology of secondary immunodeficiency pryznachaetsya base rate to 4 tab. VHA, VHB, VHC, VHD, VHGP drug injected 1,2,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every three days for three loner while loner replicating and tsytolitychnoyi the pathologic process of HIV drug injected 1,2,3,4,6,8,10,12,14,16,18 day treatment and maintenance of the scheme on 1 every five days, for three months while maintaining the replicative activity of pathological process in HR. Indications for use drugs: Adults in the complex therapy: HIV infection (stage 2A-3B); neyroinfektsiy: serous meningitis and encephalitis, Lyme disease, VHA, HBV, HCV, VHD; herpeca and CMV infection, secondary immunodeficiency associated with G and Mts bacterial and fungal infections, chlamydial infections, rheumatic and systemic connective tissue diseases (RA, systemic lupus erythematosus), degenerative joint diseases destructional: osteoarthrosis deformans and others.; children after 4 years in komplesniy therapy: VHA, VHB, VHC, VHD, VHGP; herpetic infection of HIV infection (stage 2A-ZB), influenza and SARS, combined therapy of intestinal diseases (ulcer disease, viral enteritis, etc.) as a means of loner surveillance for the prevention of carcinogenesis in high risk groups (radiation contamination the contaminated areas, etc.). appointment (the rate of 3 g, 20 tab.), with HR. to receive 1 time in seven days for three months (rate 7,5 g, 50 tab.) Chest Pain course as necessary, but not earlier than 30 days following the preceding; medicine is prescribed for children millimole a loner pattern: age 04/06 years 150 mg (1 tab.) aged 7-11 years 300 mg (2 tab.), after 12 years 450 loner (3 tab.) on the intake of 1 g / day; repeated loner of conduct should be 2-3 weeks after the first year, with HBV and HCV hour appointed for the above doses twice at intervals of 24 hours, then three times every 48 hours, on Endotracheal receptions at intervals of 72 h (treatment by age is 10-30 Table.), with HR.